Suzan Onel, Stacy Ehrlich Named 2026 Super Lawyers
We are pleased to announce that KKB partners, Suzan Onel and Stacy Ehrlich, were selected to this year’s Super Lawyers® list for Food and Drug Law. … more
We are pleased to announce that KKB partners, Suzan Onel and Stacy Ehrlich, were selected to this year’s Super Lawyers® list for Food and Drug Law. … more
Kleinfeld Kaplan and Becker is proud to announce that 8 attorneys from our firm have been recognized in the 2026 edition of … more
We are pleased to announce that KKB partners, Suzan Onel and Stacy Ehrlich, were selected to this year’s Super Lawyers® list. Suzan … more
We are pleased to announce the release of the newly updated edition of the Practicing Law Institute (PLI) Medical Devices Law and … more
KKB Partner, Suzan Onel, will be moderating the “Medical Device and Digital Health Enforcement Update” panel at the FDLI Enforcement, Litigation, and … more
On April 29, 2024, FDA announced the issuance of a final rule that amends FDA regulations to make explicit that in vitro … more
We are pleased to announce that KKB partner, Suzan Onel, was selected to this year’s Super Lawyers list. Suzan has been recognized … more
We are pleased to announce that Kleinfeld, Kaplan and Becker, LLP has been recognized by U.S. News & World Report and Best … more
KKB is pleased to announce that the U.S. State Department has invited KKB partner Suzan Onel to be the keynote speaker at … more
Kleinfeld, Kaplan & Becker, LLP, (KKB) announced today that Suzan Onel has joined the firm as a partner. KKB is a Washington, … more